Results: 32
Sustained major molecular response in the absence of any antileukaemic therapy after dasatinib treatment and autologous peripheral blood stem cell transplantation in a patient with imatinib-resistant myeloblastic-phase chronic myeloid leukaemia.
- Published in:
- 2009
- By:
- Publication type:
- Letter
miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Depletion of L-asparagine supply and apoptosis of leukemia cells induced by human glycosylasparaginase.
- Published in:
- 2009
- By:
- Publication type:
- Letter
The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1029, doi. 10.1038/leu.2008.395
- By:
- Publication type:
- Article
The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Vasculogenic mimicry of acute leukemic bone marrow stromal cells.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1039, doi. 10.1038/leu.2009.10
- By:
- Publication type:
- Article
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1062, doi. 10.1038/leu.2008.399
- By:
- Publication type:
- Article
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1152, doi. 10.1038/leu.2008.402
- By:
- Publication type:
- Article
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1118, doi. 10.1038/leu.2008.398
- By:
- Publication type:
- Article
Ectopic expression of the HLXB9 gene is associated with an altered nuclear position in t(7;12) leukaemias.
- Published in:
- 2009
- By:
- Publication type:
- Letter
The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1131, doi. 10.1038/leu.2009.1
- By:
- Publication type:
- Article
SOCS3 inhibits TPO-stimulated, but not spontaneous, megakaryocytic growth in primary myelofibrosis.
- Published in:
- 2009
- By:
- Publication type:
- Letter
t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Imatinib dose escalation for chronic phase–chronic myelogenous leukaemia patients in primary suboptimal response to imatinib 400 mg daily standard therapy.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Genes encoding multiple forms of phospholipase A<sub>2</sub> are expressed in immature forms of human leukemic blasts.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1054, doi. 10.1038/leu.2009.38
- By:
- Publication type:
- Article
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.
- Published in:
- 2009
- By:
- Publication type:
- journal article
A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Short-term intense Bcr-Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL(+) cells.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Hypermethylation of Death-Associated Protein Kinase 1 differentiates natural killer cell lines from cell lines derived from T-acute lymphoblastic leukemia.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Antiepileptic drugs reduce efficacy of methotrexate chemotherapy by downregulation of Reduced folate carrier transport activity.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1087, doi. 10.1038/leu.2009.6
- By:
- Publication type:
- Article
Caspase activation is involved in early megakaryocyte differentiation but not in platelet production from megakaryocytes.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1080, doi. 10.1038/leu.2009.7
- By:
- Publication type:
- Article
Characterization of the ubiquitin–proteasome system in bortezomib-adapted cells.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1098, doi. 10.1038/leu.2009.8
- By:
- Publication type:
- Article
Flow cytometric immunobead assay for the detection of BCR–ABL fusion proteins in leukemia patients.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 6, p. 1106, doi. 10.1038/leu.2009.93
- By:
- Publication type:
- Article
In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node.
- Published in:
- 2009
- By:
- Publication type:
- Letter